Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin as Adjunct to Misoprostol for Termination of Pregnancy
NCT05342974Phase 1Completed
- Sponsor
- University of Utah
- Start
- Apr 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of atorvastatin, sponsored by University of Utah. Primary endpoint: Interference in pregnancy progress at 7 days. Started Apr 2022; status: completed.
02
Drugs
atorvastatin
Beyond the preview
Go deeper on NCT05342974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05342974.